Evolent Health (Evolent Health) Interest Expense : $-47 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Evolent Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Evolent Health's interest expense for the three months ended in Mar. 2024 was $ -6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-47 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Evolent Health's Operating Income for the three months ended in Mar. 2024 was $ -5 Mil. Evolent Health's Interest Expense for the three months ended in Mar. 2024 was $ -6 Mil. Evolent Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evolent Health Interest Expense Historical Data

The historical data trend for Evolent Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Interest Expense Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-14.56

-28.33

-25.43

-15.57

-54.21

Evolent Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-12.90	-14.46	-14.61	-12.24	-6.00

Evolent Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47 Mil.

Evolent Health (NYSE:EVH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evolent Health's Interest Expense for the three months ended in Mar. 2024 was $-6 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $630 Mil.

Evolent Health's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Evolent Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Evolent Health (Evolent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (NYSE:EVH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

9EH:Germany

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Executives

Seth Blackley	officer: President	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Daniel Joseph Mccarthy	officer: PRESIDENT	800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Emily Ann Rafferty	officer: Chief Operating Officer	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Toyin Ajayi	director	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Mary Bridget Duffy	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Diane Holder	director	800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Richard M Jelinek	director	40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035
Frank J Williams	director, officer: Chief Executive Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
John Paul Johnson	officer: Chief Financial Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Jonathan Weinberg	officer: General Counsel	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Steve Tutewohl	officer: Chief Operating Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Tunde Sotunde	director	800 N. GLEBE RD, SUITE 500, ARLINGTON VA 22203
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305